Tyers Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $199K | Buy |
7,238
+264
| +4% | +$7.26K | 0.01% | 715 |
|
|
2019
Q2 | $231K | Hold |
6,974
| – | – | 0.01% | 696 |
|
|
2019
Q1 | $244K | Hold |
6,974
| – | – | 0.01% | 662 |
|
|
2018
Q4 | $232K | Hold |
6,974
| – | – | 0.01% | 636 |
|
|
2018
Q3 | $351K | Buy |
6,974
+1,276
| +22% | +$64.2K | 0.01% | 592 |
|
|
2018
Q2 | $341K | Hold |
5,698
| – | – | 0.01% | 531 |
|
|
2018
Q1 | $261K | Buy |
5,698
+242
| +4% | +$11.1K | 0.01% | 600 |
|
|
2017
Q4 | $217K | Buy |
5,456
+1,144
| +27% | +$45.5K | 0.01% | 662 |
|
|
2017
Q3 | $172K | Buy |
4,312
+572
| +15% | +$22.8K | 0.01% | 686 |
|
|
2017
Q2 | $161K | Buy |
3,740
+1,760
| +89% | +$75.8K | 0.01% | 662 |
|
|
2017
Q1 | $62K | Buy |
1,980
+198
| +11% | +$6.2K | ﹤0.01% | 783 |
|
|
2016
Q4 | $45K | Buy |
+1,782
| New | +$45K | ﹤0.01% | 808 |
|